Human CD8 + cytotoxic T cell responses to adenovirus capsid proteins

Adenoviruses (Ads) cause fatal disease in allogeneic stem cell transplant recipients, but there is no established therapy. Ad-specific CD8 + T cells were detected in PBMC from healthy adults at a mean frequency of 77 per 10 5 CD8 + T cells (range 8–260) by interferon-γ ELISPOT and cytokine flow cyto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virology (New York, N.Y.) N.Y.), 2006-07, Vol.350 (2), p.312-322
Hauptverfasser: Tang, Jie, Olive, Melanie, Pulmanausahakul, Rojjanaporn, Schnell, Matthias, Flomenberg, Neal, Eisenlohr, Laurence, Flomenberg, Phyllis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Adenoviruses (Ads) cause fatal disease in allogeneic stem cell transplant recipients, but there is no established therapy. Ad-specific CD8 + T cells were detected in PBMC from healthy adults at a mean frequency of 77 per 10 5 CD8 + T cells (range 8–260) by interferon-γ ELISPOT and cytokine flow cytometry assays. CD8 + T cell lines from 7 of 7 donors exhibited MHC-class-I-restricted killing of targets expressing the capsid protein hexon. In contrast, cytotoxicity against the capsid proteins fiber and penton base was weaker or not detected. Two HLA-A2-restricted hexon epitopes and one HLA-B-restricted epitope were identified, all of which are adjacent to or overlap an HLA-DP4-restricted epitope in the highly conserved C-terminus. Thus, hexon is the immunodominant T cell target among capsid proteins and contains multiple C-terminal epitopes conserved among serotypes. These data support evaluation of donor lymphocyte infusions for treatment of Ad disease post-transplant.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2006.01.024